Discover more near‑term opportunities with better event intelligence.
Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Vetmab Biosciences announced it raised $11.4 Million in an initial filing from an offering of $11.9 Million
PRIVATESep 29, 2026
Amount Raised
$11.4 Million
Round Type
Venture
San DiegoBiotechnology
Company Information
Company
Vetmab Biosciences, Inc.
Location
58 W. PORTAL AVE. #105
San Diego, California, United States
About
VETmAb BIO is a veterinary biopharmaceutical company focused on developing monoclonal antibodies ("mAbs") to treat debilitating diseases in dogs and cats. While monoclonal antibodies have provided revolutionary treatments in humans, mAbs technology has been underdeveloped in veterinary medicine.
At VETmAb BIO, we’re taking advantage of human-validated targets and designing them specifically for dogs and cats, thereby mitigating technical risk. By utilizing our proprietary technologies, we can explore potential treatments to address various unmet needs in veterinary medicine.
Fundz sees it the moment Vetmab Biosciences, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
San DiegoBiotechnology